The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pro-survival Function of Akt/Protein Kinase B in Prostate Cancer Cells
Thakkar, H., Chen, X., Tyan, F., Gim, S., Robinson, H. M., Lee, C., Pandey, S., Nwokorie, C., Onwudiwe, N. C., & Srivastava, R. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103321200 · Cited by 117
RetractedIdentification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,793
Lin, Y.-Z., Yao, S., Veach, R. A., Torgerson, T. R., & Hawiger, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14255 · Cited by 918
Chu, Z.-L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., & Ballard, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10057 · Cited by 872
Induction of NF-κB by the Akt/PKB kinase
Kane, L. P., Shapiro, V. S., Stokoe, D., & Weiss, A. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80265-6 · Cited by 846
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N. C., Treon, S. P., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.12.4525 · Cited by 669
Self-citationWang, C.-Y., Guttridge, D. C., Mayo, M. W., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5923 · Cited by 590
NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling
Kreuz, S., Siegmund, D., Scheurich, P., & Wajant, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3964-3973.2001 · Cited by 583
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
M. Joussen, A., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Döhmen, S., & P. Adamis, A. (2002) · The FASEB Journal · doi:10.1096/fj.01-0707fje · Cited by 567
Self-citationBiologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma
Hideshima, T., Nakamura, N., Chauhan, D., & Anderson, K. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204833 · Cited by 478
Self-citationTNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMP
Han, Y.-P., Tuan, T.-L., Wu, H., Hughes, M., & Garner, W. L. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.131 · Cited by 411
Hideshima, T., Chauhan, D., Schlossman, R., Richardson, P., & Anderson, K. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204623 · Cited by 394
Self-citationMitsiades, C. S., Treon, S. P., Mitsiades, N., Shima, Y., Richardson, P., Schlossman, R., Hideshima, T., & Anderson, K. C. (2001) · Blood · doi:10.1182/blood.v98.3.795 · Cited by 392
Self-citationBiologic sequelae of nuclear factor–κB blockade in multiple myeloma: therapeutic applications
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N., Treon, S. P., & Anderson, K. C. (2002) · Blood · doi:10.1182/blood.v99.11.4079 · Cited by 367
Self-citationConstitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer
Chen, X., Thakkar, H., Tyan, F., Gim, S., Robinson, H., Lee, C., Pandey, S. K., Nwokorie, C., Onwudiwe, N., & Srivastava, R. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204736 · Cited by 298
Phosphatidylinositol 3-Kinase/Akt Activity Regulates c-FLIP Expression in Tumor Cells
Panka, D. J., Mano, T., Suhara, T., Walsh, K., & Mier, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000569200 · Cited by 269
Elevated Akt Activity Protects the Prostate Cancer Cell Line LNCaP from TRAIL-induced Apoptosis
Nesterov, A., Lu, X., Johnson, M., Miller, G. J., Ivashchenko, Y., & Kraft, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005196200 · Cited by 269
Qin, Z.-H., Chen, R.-W., Wang, Y., Nakai, M., Chuang, D.-M., & Chase, T. N. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04023.1999 · Cited by 230
Role of NF-κB in the Rescue of Multiple Myeloma Cells From Glucocorticoid-Induced Apoptosis by Bcl-2
Feinman, R., Koury, J., Thames, M., Barlogie, B., Epstein, J., & Siegel, D. S. (1999) · Blood · doi:10.1182/blood.v93.9.3044 · Cited by 201
Heck, S., Lezoualc'h, F., Engert, S., & Behl, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9828 · Cited by 200
Hu, Y., Qiao, L., Wang, S., Rong, S.-B., Meuillet, E. J., Berggren, M., Gallegos, A., Powis, G., & Kozikowski, A. P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000117y · Cited by 195
Chauhan, D., Pandey, P., Hideshima, T., Treon, S., Raje, N., Davies, F. E., Shima, Y., Tai, Y.-T., Rosen, S., Avraham, S., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003428200 · Cited by 185
Self-citationInsulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines
Georgii-Hemming, P., Wiklund, H., Ljunggren, O., & Nilsson, K. (1996) · Blood · doi:10.1182/blood.v88.6.2250.bloodjournal8862250 · Cited by 177
Insulin-like growth factor I is a dual effector of multiple myeloma cell growth
Ge, N.-L., & Rudikoff, S. (2000) · Blood · doi:10.1182/blood.v96.8.2856 · Cited by 175
Burns, T. F., & El‐Deiry, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103516200 · Cited by 171
Chauhan, D., Auclair, D., Robinson, E. K., Hideshima, T., Li, G., Podar, K., Gupta, D., Richardson, P., Schlossman, R. L., Krett, N., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205205 · Cited by 165
Self-citationNuclear Factor-κB Contributes to Excitotoxin-Induced Apoptosis in Rat Striatum
Qin, Z.-H., Wang, Y., Nakai, M., & Chase, T. N. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.33 · Cited by 163
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Anderson, K. C., & Treon, S. P. (2002) · Blood · doi:10.1182/blood.v99.6.2162 · Cited by 159
Self-citationKolenko, V. M., Bloom, T., Rayman, P. A., Bukowski, R. M., Hsi, E. D., & Finke, J. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.590 · Cited by 115
Jelinek, D. F., Witzig, T. E., & Arendt, B. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.487 · Cited by 103
Xu, F., Gardner, A. M., Tu, Y., Michl, P., Prager, D., & Lichtenstein, A. K. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.592708.x · Cited by 101
Pons, S., & Torres‐Alemán, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004531200 · Cited by 97
Poulaki, V., Mitsiades, N., Romero, M. E., & Tsokos, M. (2001) · PubMed · Cited by 87
Self-citationXiao, C. W., Ash, K. J., & Tsang, B. K. (2001) · Endocrinology · doi:10.1210/endo.142.2.7957 · Cited by 81
The Role of the Insulin‐like Growth Factor‐I Receptor in Cancer
LeRoith, D., Werner, H., Neuenschwander, S., Kalebic, T., & Helman, L. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb26689.x · Cited by 79
Ogawa, M., Nishiura, T., Oritani, K., Yoshida, H., Yoshimura, M., Okajima, Y., Ishikawa, J., Hashimoto, K., Matsumura, I., Tomiyama, Y., et al. (2000) · PubMed · Cited by 74
Gründker, C., Schulz, K., Günthert, A. R., & Emons, G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6859 · Cited by 72
Ye, J., Ding, M., Zhang, X., Rojanasakul, Y., Nedospasov, S. A., Vallyathan, V., Castranova, V., & Shi, X. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006969008056 · Cited by 46
Modulation of JunD·AP-1 DNA Binding Activity by AP-1-associated Factor 1 (AF-1)
Powers, C., Krutzsch, H. C., & Gardner, K. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.30089 · Cited by 24
Cited by
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
Richardson, P. G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S. V., Srkalovic, G., Alsina, M., Alexanian, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030288 · Cited by 2,632
Self-citationMesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Murphy, M. B., Moncivais, K., & Caplan, A. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.94 · Cited by 1,231
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932
Self-citationMolecular sequelae of proteasome inhibition in human multiple myeloma cells
Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., Libermann, T. A., Treon, S. P., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202445099 · Cited by 741
Self-citationChauhan, D., Catley, L., Li, G., Podar, K., Hideshima, T., Velankar, M., Mitsiades, C., Mitsiades, N., Yasui, H., Letai, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.013 · Cited by 694
“As in our prior studies (Chauhan and Anderson, 2003; Mitsiades et al., 2002a ), both rhIL-6 and rhIGF-I block Dex-induced decreases in MM.1S cell viability.”
ResultSelf-citation
Metadata
- Authors
- Mitsiades, C. S., Mitsiades, N., Poulaki, V., Schlossman, R., Akiyama, M., Chauhan, D., Hideshima, T., Treon, S. P., Munshi, N. C., Richardson, P. G., & Anderson, K. C.
- Venue
- Oncogene
- Published
- 2002-08-13
- Volume
- 21
- Issue
- 37
- Pages
- 5673-5683
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2024969918
- Cited by
- 464
- References
- 42
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.